First Time Loading...
V

Vor Biopharma Inc
NASDAQ:VOR

Watchlist Manager
Vor Biopharma Inc
NASDAQ:VOR
Watchlist
Price: 1.73 USD 1.17%
Updated: Apr 18, 2024

Intrinsic Value

VOR's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. [ Read More ]

The intrinsic value of one VOR stock under the Base Case scenario is 2.01 USD. Compared to the current market price of 1.73 USD, Vor Biopharma Inc is Undervalued by 14%.

Key Points:
VOR Intrinsic Value
Base Case
2.01 USD
Undervaluation 14%
Intrinsic Value
Price
V
Worst Case
Base Case
Best Case

Valuation Backtest
Vor Biopharma Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling VOR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Vor Biopharma Inc

Provide an overview of the primary business activities
of Vor Biopharma Inc.

What unique competitive advantages
does Vor Biopharma Inc hold over its rivals?

What risks and challenges
does Vor Biopharma Inc face in the near future?

Has there been any significant insider trading activity
in Vor Biopharma Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vor Biopharma Inc.

Provide P/S
for Vor Biopharma Inc.

Provide P/E
for Vor Biopharma Inc.

Provide P/OCF
for Vor Biopharma Inc.

Provide P/FCFE
for Vor Biopharma Inc.

Provide P/B
for Vor Biopharma Inc.

Provide EV/S
for Vor Biopharma Inc.

Provide EV/GP
for Vor Biopharma Inc.

Provide EV/EBITDA
for Vor Biopharma Inc.

Provide EV/EBIT
for Vor Biopharma Inc.

Provide EV/OCF
for Vor Biopharma Inc.

Provide EV/FCFF
for Vor Biopharma Inc.

Provide EV/IC
for Vor Biopharma Inc.

Show me price targets
for Vor Biopharma Inc made by professional analysts.

What are the Revenue projections
for Vor Biopharma Inc?

How accurate were the past Revenue estimates
for Vor Biopharma Inc?

What are the Net Income projections
for Vor Biopharma Inc?

How accurate were the past Net Income estimates
for Vor Biopharma Inc?

What are the EPS projections
for Vor Biopharma Inc?

How accurate were the past EPS estimates
for Vor Biopharma Inc?

What are the EBIT projections
for Vor Biopharma Inc?

How accurate were the past EBIT estimates
for Vor Biopharma Inc?

Compare the revenue forecasts
for Vor Biopharma Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vor Biopharma Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vor Biopharma Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vor Biopharma Inc compared to its peers.

Compare the P/E ratios
of Vor Biopharma Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Vor Biopharma Inc with its peers.

Analyze the financial leverage
of Vor Biopharma Inc compared to its main competitors.

Show all profitability ratios
for Vor Biopharma Inc.

Provide ROE
for Vor Biopharma Inc.

Provide ROA
for Vor Biopharma Inc.

Provide ROIC
for Vor Biopharma Inc.

Provide ROCE
for Vor Biopharma Inc.

Provide Gross Margin
for Vor Biopharma Inc.

Provide Operating Margin
for Vor Biopharma Inc.

Provide Net Margin
for Vor Biopharma Inc.

Provide FCF Margin
for Vor Biopharma Inc.

Show all solvency ratios
for Vor Biopharma Inc.

Provide D/E Ratio
for Vor Biopharma Inc.

Provide D/A Ratio
for Vor Biopharma Inc.

Provide Interest Coverage Ratio
for Vor Biopharma Inc.

Provide Altman Z-Score Ratio
for Vor Biopharma Inc.

Provide Quick Ratio
for Vor Biopharma Inc.

Provide Current Ratio
for Vor Biopharma Inc.

Provide Cash Ratio
for Vor Biopharma Inc.

What is the historical Revenue growth
over the last 5 years for Vor Biopharma Inc?

What is the historical Net Income growth
over the last 5 years for Vor Biopharma Inc?

What is the current Free Cash Flow
of Vor Biopharma Inc?

Financials

Balance Sheet Decomposition
Vor Biopharma Inc

Current Assets 140.8m
Cash & Short-Term Investments 137.2m
Other Current Assets 3.6m
Non-Current Assets 57.3m
PP&E 50.1m
Other Non-Current Assets 7.2m
Current Liabilities 15.6m
Accounts Payable 815k
Accrued Liabilities 14.7m
Other Current Liabilities 50k
Non-Current Liabilities 31.8m
Other Non-Current Liabilities 31.8m
Efficiency

Earnings Waterfall
Vor Biopharma Inc

Revenue
0 USD
Operating Expenses
-126m USD
Operating Income
-126m USD
Other Expenses
8.2m USD
Net Income
-117.9m USD

Free Cash Flow Analysis
Vor Biopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

VOR Profitability Score
Profitability Due Diligence

Vor Biopharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score

Vor Biopharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

VOR Solvency Score
Solvency Due Diligence

Vor Biopharma Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Vor Biopharma Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VOR Price Targets Summary
Vor Biopharma Inc

There are no price targets for VOR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

VOR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

VOR Price
Vor Biopharma Inc

1M 1M
-10%
6M 6M
-21%
1Y 1Y
-60%
3Y 3Y
-94%
5Y 5Y
-90%
10Y 10Y
-90%
Annual Price Range
1.73
52w Low
1.655
52w High
5.33
Price Metrics
Average Annual Return -38.4%
Standard Deviation of Annual Returns 8.96%
Max Drawdown -97%
Shares Statistics
Market Capitalization 117.5m USD
Shares Outstanding 68 215 800
Percentage of Shares Shorted 10.62%

VOR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Vor Biopharma Inc

Country

United States of America

Industry

Biotechnology

Market Cap

117.5m USD

Dividend Yield

0%

Description

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 135 full-time employees. The company went IPO on 2021-02-05. The firm is engaged in combining a novel patient engineering approach with targeted therapies to provide solutions for patients suffering from hematological malignancies. Its proprietary platform leverages expertise in hematopoietic stem cell (HSC) biology, genome engineering and targeted therapy development to genetically modify HSCs to remove surface targets expressed by cancer cells. VOR33 is the lead product candidate consisting of genome-edited hematopoietic stem and progenitor cells that have been engineered to lack the CD33 protein. The company is designed to replace the standard of care in transplant settings for patients suffering from acute myeloid leukemia (AML) and other blood cancers. VBP101 is a Phase I/II a multicenter, open-label, first-in-human study of VOR33 in participants with AML. The company offers VCAR33 programs that are chimeric antigen receptor T (CAR-T) cell therapy candidates designed to target CD33.

Contact

MASSACHUSETTS
Cambridge
215 First Street, Suite 430
+16176556580.0
https://www.vorbio.com/

IPO

2021-02-05

Employees

135

Officers

President, CEO & Director
Dr. Robert Ang M.B.A., M.D., MBBS
Chief Financial Officer
Dr. Nathan D. Jorgensen M.B.A., Ph.D.
Chief Scientific Officer
Dr. Tirtha Chakraborty Ph.D.
Scientific Founder & Chairman of Scientific Advisory Board
Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D.
Chief People Officer
Ms. Tania Philipp
Chief Regulatory Officer
Dr. Robert G. Pietrusko Pharm. D., Pharm.D.
Show More
Chief Commercial Officer
Mr. John C. King M.B.A.
Chief Medical Officer
Dr. Eyal C. Attar M.D.
Senior Vice President of Portfolio Strategy & Program Management
Mr. Samir Vattompadam M.S.
Senior VP & Head of Quality
Mr. David Phillips M.B.A.
Show Less

See Also

Discover More
What is the Intrinsic Value of one VOR stock?

The intrinsic value of one VOR stock under the Base Case scenario is 2.01 USD.

Is VOR stock undervalued or overvalued?

Compared to the current market price of 1.73 USD, Vor Biopharma Inc is Undervalued by 14%.